Lin Liu, Ph.D., FAPS, received his Ph.D. in Biochemistry from the Chinese Academy of Sciences and had his postdoctoral training at the University of Pennsylvania. He took his first faculty appointment at East Carolina University and joined the OSU College of Veterinary Medicine as Associate Professor of Physiological Sciences. He was then promoted to Full Professor, and appointed as Lundberg-Kienlen Endowed Professor/Chair in Biomedical Research and Regents Professor. Dr. Liu was selected as a Riata Faculty Fellow in the OSU School of Entrepreneurship. He was also elected as a Fellow of the American Physiological Society.
Dr. Liu is the Founding Director of the Oklahoma Center for Respiratory and Infectious Diseases and the Interdisciplinary Program in Regenerative Medicine at OSU. Dr. Liu has also directed the Lung Biology and Toxicology Laboratory. He has established a nationally visible respiratory and infectious disease research program. His current research interests are respiratory infections including SARS-CoV-2, influenza virus, and Mycobacterium tuberculosis; pathogenesis of pulmonary diseases; and stem cell-based therapy and human tissue engineering. As principal investigator, Dr. Liu has received over $40 million in grants (as of 12/2022) from federal agencies (National Institutes of Health and U.S. Department of Agriculture), foundations (American Heart Association and March of Dimes), and other local agencies.
Dr. Liu has also served on grant review panels for the NIH and many other granting entities. He has served as Chair of the OSU Biomedical Sciences Group of the Graduate Faculty Council. Dr. Liu has been a member of the Steering Committee for the Physiological Genomics Interest Group of the American Physiological Society. Dr. Liu has a long track record in training and mentoring rising scientists. Dr. Liu has received several awards including the Pfizer Award for Research Excellence and the OSU Regents Distinguished Research Award.